{"pmid":32473231,"title":"Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.","text":["Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.","J Infect","Varikasuvu, Seshadri Reddy","Dutt, Naveen","32473231"],"journal":"J Infect","authors":["Varikasuvu, Seshadri Reddy","Dutt, Naveen"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473231","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jinf.2020.05.038","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668255193404276736,"score":9.490897,"similar":[{"pmid":32370577,"title":"Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.","text":["Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.","Background: To investigate the risk factors related to aggravation and clinical outcomes in coronavirus disease 2019 (COVID-19) patients.Methods: We performed a retrospective study on the risk factors for disease progression of cases with COVID-19. Based on the clinical types, the patients were divided into a progression group and an improvement group. Multivariable logistic regression and ROC curve analysis were performed to explore the risk factors for disease progression.Results: A total of 101 patients were included in this study; diseases progression occurred in 17 patients, 84 patients improved, 6 were transferred to intensive care unit (ICU), and 5 died. The mean time to obtain negative nucleic acid results was 12.5 +/- 5.0 days. Multivariate logistic analysis indicated that age (OR, 0.104; p = .002), C-reactive protein (CRP) (OR, 0.093; p < .001) and lymphocyte count (OR, 3.397; p = .022) were risk factors for disease progression. ROC curve analysis revealed that the AUC of age, CRP and lymphocyte count for disease progression were 0.873, 0.911 and 0.817, respectively.Conclusions: Older age increased CRP and decreased lymphocyte count resulted in potential risk factors for COVID-19 progression. This may be helpful in identifying patients whose condition worsens at an early stage.","Infect Dis (Lond)","Hou, Wei","Zhang, Wei","Jin, Ronghua","Liang, Lianchun","Xu, Bin","Hu, Zhongjie","32370577"],"abstract":["Background: To investigate the risk factors related to aggravation and clinical outcomes in coronavirus disease 2019 (COVID-19) patients.Methods: We performed a retrospective study on the risk factors for disease progression of cases with COVID-19. Based on the clinical types, the patients were divided into a progression group and an improvement group. Multivariable logistic regression and ROC curve analysis were performed to explore the risk factors for disease progression.Results: A total of 101 patients were included in this study; diseases progression occurred in 17 patients, 84 patients improved, 6 were transferred to intensive care unit (ICU), and 5 died. The mean time to obtain negative nucleic acid results was 12.5 +/- 5.0 days. Multivariate logistic analysis indicated that age (OR, 0.104; p = .002), C-reactive protein (CRP) (OR, 0.093; p < .001) and lymphocyte count (OR, 3.397; p = .022) were risk factors for disease progression. ROC curve analysis revealed that the AUC of age, CRP and lymphocyte count for disease progression were 0.873, 0.911 and 0.817, respectively.Conclusions: Older age increased CRP and decreased lymphocyte count resulted in potential risk factors for COVID-19 progression. This may be helpful in identifying patients whose condition worsens at an early stage."],"journal":"Infect Dis (Lond)","authors":["Hou, Wei","Zhang, Wei","Jin, Ronghua","Liang, Lianchun","Xu, Bin","Hu, Zhongjie"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32370577","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1080/23744235.2020.1759817","keywords":["covid-19","risk factors outcome"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138496454098945,"score":46.673462},{"pmid":32452598,"title":"In response: Diabetes is a risk factor for the progression and prognosis of COVID-19.","text":["In response: Diabetes is a risk factor for the progression and prognosis of COVID-19.","The article cited does not differentiate between Type I and Type II diabetes. More information is needed to properly assess risk.","Diabetes Metab Res Rev","Blanke, Charles D","32452598"],"abstract":["The article cited does not differentiate between Type I and Type II diabetes. More information is needed to properly assess risk."],"journal":"Diabetes Metab Res Rev","authors":["Blanke, Charles D"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452598","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/dmrr.3331","keywords":["covid","diabetes","risk"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667881798544130048,"score":45.832478},{"pmid":32456948,"pmcid":"PMC7165120","title":"Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.","text":["Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.","BACKGROUND AND AIM: A novel coronavirus severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) caused pneumonia, Coronavirus Disease 2019 (COVID-19), broke out in Wuhan, China in December 2019, and spread all over the world. Patients with COVID-19 showed huge differences in the hospital stay, progression, and prognosis. As reported, the comorbidities may play an important role in COVID-19. Here, we aim to address the role of cardiovascular disease (CVD) in the progression and prognosis of COVID-19. METHODS AND RESULTS: Eighty-three confirmed COVID-19 patients were divided into CVD (n = 42) and non-CVD (n = 41) group according to their medical history. Medical records including demographic data, medical history, clinical characteristics, laboratory examinations, chest computed tomography (CT), and treatment measures were collected, analyzed, and compared between the two groups. COVID-19 patients with CVD showed (1) more severe pathological changes in the lungs, (2) elevated injury-related enzymes including alpha-hydroxybutyrate dehydrogenase (HDBH), lactic dehydrogenase (LDH), gamma-glutamyltransferase (GGT), creatine kinase (CK), and alanine aminotransferase (ALT), (3) significantly increased uncontrolled inflammation related markers, such as c-reactive protein (CRP), interleukin (IL)-6, serum ferritin, erythrocyte sedimentation rate (ESR), and serum amyloid A (SAA), (4) serious hypercoagulable status reflected by increased D-dimer and serum fibrinogen (FIB), and (5) higher mortality, compared to COVID-19 patients without CVD. CONCLUSIONS: Our data indicated that CVD is a strong risk factor for rapid progression and bad prognosis of COVID-19. More intensive medical care should be applied to patients with CVD to prevent rapid deterioration of the disease.","Nutr Metab Cardiovasc Dis","Li, Mingyue","Dong, Yalan","Wang, Haijun","Guo, Weina","Zhou, Haifeng","Zhang, Zili","Tian, Chunxia","Du, Keye","Zhu, Rui","Wang, Li","Zhao, Lei","Fan, Heng","Luo, Shanshan","Hu, Desheng","32456948"],"abstract":["BACKGROUND AND AIM: A novel coronavirus severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) caused pneumonia, Coronavirus Disease 2019 (COVID-19), broke out in Wuhan, China in December 2019, and spread all over the world. Patients with COVID-19 showed huge differences in the hospital stay, progression, and prognosis. As reported, the comorbidities may play an important role in COVID-19. Here, we aim to address the role of cardiovascular disease (CVD) in the progression and prognosis of COVID-19. METHODS AND RESULTS: Eighty-three confirmed COVID-19 patients were divided into CVD (n = 42) and non-CVD (n = 41) group according to their medical history. Medical records including demographic data, medical history, clinical characteristics, laboratory examinations, chest computed tomography (CT), and treatment measures were collected, analyzed, and compared between the two groups. COVID-19 patients with CVD showed (1) more severe pathological changes in the lungs, (2) elevated injury-related enzymes including alpha-hydroxybutyrate dehydrogenase (HDBH), lactic dehydrogenase (LDH), gamma-glutamyltransferase (GGT), creatine kinase (CK), and alanine aminotransferase (ALT), (3) significantly increased uncontrolled inflammation related markers, such as c-reactive protein (CRP), interleukin (IL)-6, serum ferritin, erythrocyte sedimentation rate (ESR), and serum amyloid A (SAA), (4) serious hypercoagulable status reflected by increased D-dimer and serum fibrinogen (FIB), and (5) higher mortality, compared to COVID-19 patients without CVD. CONCLUSIONS: Our data indicated that CVD is a strong risk factor for rapid progression and bad prognosis of COVID-19. More intensive medical care should be applied to patients with CVD to prevent rapid deterioration of the disease."],"journal":"Nutr Metab Cardiovasc Dis","authors":["Li, Mingyue","Dong, Yalan","Wang, Haijun","Guo, Weina","Zhou, Haifeng","Zhang, Zili","Tian, Chunxia","Du, Keye","Zhu, Rui","Wang, Li","Zhao, Lei","Fan, Heng","Luo, Shanshan","Hu, Desheng"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32456948","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.numecd.2020.04.013","keywords":["covid-19","cardiovascular disease","prognosis"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668141322616176640,"score":43.796906},{"pmid":32233013,"title":"Diabetes is a risk factor for the progression and prognosis of COVID-19.","text":["Diabetes is a risk factor for the progression and prognosis of COVID-19.","BACKGOUND: To figure out whether diabetes is a risk factor influencing the progression and prognosis of 2019 novel coronavirus disease (COVID-19). METHODS: A total of 174 consecutive patients confirmed with COVID-19 were studied. Demographic data, medical history, symptoms and signs, laboratory findings, chest computed tomography (CT) as well the treatment measures were collected and analysed. RESULTS: We found that COVID-19 patients without other comorbidities but with diabetes (n = 24) were at higher risk of severe pneumonia, release of tissue injury-related enzymes, excessive uncontrolled inflammation responses and hypercoagulable state associated with dysregulation of glucose metabolism. Furthermore, serum levels of inflammation-related biomarkers such as IL-6, C-reactive protein, serum ferritin and coagulation index, D-dimer, were significantly higher (P < .01) in diabetic patients compared with those without, suggesting that patients with diabetes are more susceptible to an inflammatory storm eventually leading to rapid deterioration of COVID-19. CONCLUSIONS: Our data support the notion that diabetes should be considered as a risk factor for a rapid progression and bad prognosis of COVID-19. More intensive attention should be paid to patients with diabetes, in case of rapid deterioration.","Diabetes Metab Res Rev","Guo, Weina","Li, Mingyue","Dong, Yalan","Zhou, Haifeng","Zhang, Zili","Tian, Chunxia","Qin, Renjie","Wang, Haijun","Shen, Yin","Du, Keye","Zhao, Lei","Fan, Heng","Luo, Shanshan","Hu, Desheng","32233013"],"abstract":["BACKGOUND: To figure out whether diabetes is a risk factor influencing the progression and prognosis of 2019 novel coronavirus disease (COVID-19). METHODS: A total of 174 consecutive patients confirmed with COVID-19 were studied. Demographic data, medical history, symptoms and signs, laboratory findings, chest computed tomography (CT) as well the treatment measures were collected and analysed. RESULTS: We found that COVID-19 patients without other comorbidities but with diabetes (n = 24) were at higher risk of severe pneumonia, release of tissue injury-related enzymes, excessive uncontrolled inflammation responses and hypercoagulable state associated with dysregulation of glucose metabolism. Furthermore, serum levels of inflammation-related biomarkers such as IL-6, C-reactive protein, serum ferritin and coagulation index, D-dimer, were significantly higher (P < .01) in diabetic patients compared with those without, suggesting that patients with diabetes are more susceptible to an inflammatory storm eventually leading to rapid deterioration of COVID-19. CONCLUSIONS: Our data support the notion that diabetes should be considered as a risk factor for a rapid progression and bad prognosis of COVID-19. More intensive attention should be paid to patients with diabetes, in case of rapid deterioration."],"journal":"Diabetes Metab Res Rev","authors":["Guo, Weina","Li, Mingyue","Dong, Yalan","Zhou, Haifeng","Zhang, Zili","Tian, Chunxia","Qin, Renjie","Wang, Haijun","Shen, Yin","Du, Keye","Zhao, Lei","Fan, Heng","Luo, Shanshan","Hu, Desheng"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32233013","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1002/dmrr.3319","keywords":["covid-19","diabetes","prognosis"],"topics":["Diagnosis"],"weight":1,"_version_":1666138492208414720,"score":42.013844},{"pmid":32361327,"pmcid":"PMC7187844","title":"Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China.","text":["Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China.","BACKGROUND: A few studies have revealed the clinical characteristics of hospitalized patients with COVID-19. However, predictive factors for the outcomes remain unclear. OBJECTIVE: Attempted to determine the predictive factors for the poor outcomes of patients with COVID-19. STUDY DESIGN: This is a single-center, retrospective study. Clinical, laboratory, and treatment data were collected and analyzed from 111 hospitalized patients with laboratory-confirmed COVID-19 in Union Hospital. The gathered data of discharged and deteriorated patients were compared. RESULTS: Among these 111 patients, 93 patients were discharged and 18 patients were deteriorated. The lymphocyte count (0.56 G/L [0.47-0.63] vs 1.30 G/L [0.95-1.65]) was lower in the deteriorated group than those in the discharged group. The numbers of pulmonary lobe involved (5.00 [5.00-5.00] vs 4.00 [2.00-5.00]), serum C-reactive protein (CRP, 79.52 mg/L [61.25-102.98] vs 7.93 mg/L [3.14-22.50]), IL-6 (35.72 pg/mL [9.24-85.19] vs 5.09 pg/mL [3.16-9.72]), and IL-10 (5.35 pg/mL [4.48-7.84] vs 3.97 pg/mL [3.34-4.79]) concentrations in deteriorated patients were elevated compared with discharged patients. Multivariate logistic regression analysis showed that male gender (OR, 24.8 [1.8-342.1]), comorbidity (OR, 52.6 [3.6-776.4]), lymphopenia (OR, 17.3 [1.1-261.8]), and elevated CRP (OR, 96.5 [4.6-2017.6]) were the independent risk factors for the poor prognosis in COVID-19 patients. CONCLUSIONS: This finding would facilitate the early identification of high-risk COVID-19 patients.","J Clin Virol","Zhang, Jun","Yu, Miao","Tong, Song","Liu, Lu-Yu","Tang, Liang-V","32361327"],"abstract":["BACKGROUND: A few studies have revealed the clinical characteristics of hospitalized patients with COVID-19. However, predictive factors for the outcomes remain unclear. OBJECTIVE: Attempted to determine the predictive factors for the poor outcomes of patients with COVID-19. STUDY DESIGN: This is a single-center, retrospective study. Clinical, laboratory, and treatment data were collected and analyzed from 111 hospitalized patients with laboratory-confirmed COVID-19 in Union Hospital. The gathered data of discharged and deteriorated patients were compared. RESULTS: Among these 111 patients, 93 patients were discharged and 18 patients were deteriorated. The lymphocyte count (0.56 G/L [0.47-0.63] vs 1.30 G/L [0.95-1.65]) was lower in the deteriorated group than those in the discharged group. The numbers of pulmonary lobe involved (5.00 [5.00-5.00] vs 4.00 [2.00-5.00]), serum C-reactive protein (CRP, 79.52 mg/L [61.25-102.98] vs 7.93 mg/L [3.14-22.50]), IL-6 (35.72 pg/mL [9.24-85.19] vs 5.09 pg/mL [3.16-9.72]), and IL-10 (5.35 pg/mL [4.48-7.84] vs 3.97 pg/mL [3.34-4.79]) concentrations in deteriorated patients were elevated compared with discharged patients. Multivariate logistic regression analysis showed that male gender (OR, 24.8 [1.8-342.1]), comorbidity (OR, 52.6 [3.6-776.4]), lymphopenia (OR, 17.3 [1.1-261.8]), and elevated CRP (OR, 96.5 [4.6-2017.6]) were the independent risk factors for the poor prognosis in COVID-19 patients. CONCLUSIONS: This finding would facilitate the early identification of high-risk COVID-19 patients."],"journal":"J Clin Virol","authors":["Zhang, Jun","Yu, Miao","Tong, Song","Liu, Lu-Yu","Tang, Liang-V"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32361327","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jcv.2020.104392","keywords":["coronavirus disease 2019","predictive factors","prognosis"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495898353664,"score":41.95245}]}